Anti-GAD65; Anti GAD; AGAD; Glutamic Acid Decarboxylase-65 Antibodies
Back to Test Catalogue
Glutamic Acid Decarboxylase (GAD65) Antibodies, Serum
Test ID: GADAB S
Test
Aliases/Synonyms
Method
ELISA
Platform
Euroimmun Analyzer I
Report Includes
Glutamic Acid Decarboxylase (GAD65) Antibodies
Specimens
Serum
Clinical Utility
GAD65 antibodies are associated with systemic autoimmune diseases, including type 1 diabetes mellitus, thyroiditis and pernicious anemia. At high levels, they may be associated with neurological autoimmunity.
Test Location
London Health Sciences Centre, 339 Windermere Road, London ON N6A 5A5
Test Version
25-Jul-2024
Specimen
Specimens
Serum
Collection Containers
Preferred
Gold top (clot activator & gel)
Acceptable
["Red top (no additive)"]
Sample Volume
1 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | 7 days |
|---|---|
| Refrigerated | 14 days |
| Frozen | 30 days |
Additional Stability Information
Freezing and thawing may lead to a loss of activity
Rejection Criteria
| Hemolysis | Present |
|---|---|
| Lipemia | Present |
| Specimen | Plasma |
Test Version
25-Jul-2024
Performance / Interpretation
Method
ELISA
Platform
Euroimmun Analyzer I
Turnaround Time
7 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Anti-GAD65 | IU/mL |
|
||
Test Location
London Health Sciences Centre, 339 Windermere Road, London ON N6A 5A5
Test Version
25-Jul-2024
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| GADAB S | 63508Anti-GAD65 Elisa,Serum | IU/mL |
Test Version
25-Jul-2024